Global General OTC
Market Report
2024
The global General OTC market size will be USD 50254.2 million in 2024. Rising aging population is expected to boost sales to USD 75563.74 million by 2031, with a Compound Annual Growth Rate (CAGR) of 6.00% from 2024 to 2031.
The base year for the calculation is 2023 and 2019 to 2023 will be historical period. The year 2024 will be estimated one while the forecasted data will be from year 2025 to 2031. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
Share your contact details to receive free updated sample copy/pages of the recently published edition of General OTC Market Report 2024.
According to Cognitive Market Research, the global General OTC market size will be USD 50254.2 million in 2024. It will expand at a compound annual growth rate (CAGR) of 6.00% from 2024 to 2031.
Base Year | 2023 |
Historical Data Time Period | 2019-2023 |
Forecast Period | 2024-2031 |
Global General OTC Market Sales Revenue 2024 | $ 50254.2 Million |
Global General OTC Market Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 6% |
North America General OTC Sales Revenue 2024 | $ 20101.7 Million |
North America General OTC Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 4.2% |
United States General OTC Sales Revenue 2024 | $ 15860.2 Million |
United States General OTC Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 4% |
Canada General OTC Sales Revenue 2024 | $ 2412.2 Million |
Canada General OTC Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 5% |
Mexico General OTC Sales Revenue 2024 | $ 1829.25 Million |
Mexico General OTC Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 4.7% |
Europe General OTC Sales Revenue 2024 | $ 15076.3 Million |
Europe General OTC Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 4.5% |
United Kingdom General OTC Sales Revenue 2024 | $ 2532.81 Million |
United Kingdom General OTC Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 5.3% |
France General OTC Sales Revenue 2024 | $ 1387.02 Million |
France General OTC Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 3.7% |
Germany General OTC Sales Revenue 2024 | $ 2985.1 Million |
Germany General OTC Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 4.7% |
Italy General OTC Sales Revenue 2024 | $ 1296.56 Million |
Italy General OTC Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 3.9% |
Russia General OTC Sales Revenue 2024 | $ 2336.82 Million |
Russia General OTC Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 3.5% |
Spain General OTC Sales Revenue 2024 | $ 1236.25 Million |
Spain General OTC Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 3.6% |
Rest of Europe General OTC Sales Revenue 2024 | $ 2336.82 Million |
Rest of Europe General OTC Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 3.2% |
Asia Pacific General OTC Sales Revenue 2024 | $ 11558.5 Million |
Asia Pacific General OTC Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 8% |
China General OTC Sales Revenue 2024 | $ 5201.31 Million |
China General OTC Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 7.5% |
Japan General OTC Sales Revenue 2024 | $ 1595.07 Million |
Japan General OTC Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 6.5% |
Korea General OTC Sales Revenue 2024 | $ 1155.85 Million |
Korea General OTC Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 7.1% |
India General OTC Sales Revenue 2024 | $ 1387.02 Million |
India General OTC Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 9.8% |
Australia General OTC Sales Revenue 2024 | $ 601.04 Million |
Australia General OTC Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 7.7% |
Rest of APAC General OTC Sales Revenue 2024 | $ 820.65 Million |
Rest of APAC General OTC Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 7.8% |
South America General OTC Sales Revenue 2024 | $ 2512.71 Million |
South America General OTC Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 5.4% |
Brazil General OTC Sales Revenue 2024 | $ 1075.44 Million |
Brazil General OTC Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 6% |
Argentina General OTC Sales Revenue 2024 | $ 422.14 Million |
Argentina General OTC Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 6.3% |
Colombia General OTC Sales Revenue 2024 | $ 223.63 Million |
Colombia General OTC Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 5.2% |
Peru General OTC Sales Revenue 2024 | $ 206.04 Million |
Peru General OTC Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 5.6% |
Chile General OTC Sales Revenue 2024 | $ 180.92 Million |
Chile General OTC Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 5.7% |
Rest of South America General OTC Sales Revenue 2024 | $ 404.55 Million |
Rest of South America General OTC Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 4.5% |
Middle East and Africa General OTC Sales Revenue 2024 | $ 1005.08 Million |
Middle East and Africa General OTC Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 5.7% |
Turkey General OTC Sales Revenue 2024 | $ 86.44 Million |
Turkey General OTC Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 5.2% |
Nigeria General OTC Sales Revenue 2024 | $ 105.53 Million |
Nigeria General OTC Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 4.8% |
Egypt General OTC Sales Revenue 2024 | $ 105.53 Million |
Egypt General OTC Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 6% |
South Africa General OTC Sales Revenue 2024 | $ 158.8 Million |
South Africa General OTC Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 6.7% |
GCC Countries General OTC Sales Revenue 2024 | $ 430.18 Million |
GCC Countries General OTC Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 6.5% |
Rest of MEA General OTC Sales Revenue 2024 | $ 118.6 Million |
Rest of MEA General OTC Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 4.7% |
Market Drivers:
| |
Market Restrains:
| |
Market Trends:
|
Market Split by Type |
|
Market Split by Application |
|
List of Competitors |
|
Regional Analysis |
|
Country Analysis |
|
Key Qualitative Information Covered |
|
Report scope is customizable as we have a huge database of General OTC industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
General OTC Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
The Generic Over-the-Counter (OTC) Market is a pharmaceutical industry segment that encompasses medications that are accessible to consumers without a prescription. These medications are available for purchase at pharmacies, supermarkets, and online retailers. They are employed to address a variety of prevalent health conditions, including allergies, colds, and minor chronic pain. Growing consumer awareness of health and wellness, a growing trend toward self-medication, an elderly population, favorable laws and regulations, the expiration of patents on prescription medications, technological advancements, and a variety of economic factors are the primary drivers of the General OTC Market. On the other hand, the market is confronted with a variety of restraining factors, including economic fluctuations, patent expirations that result in increased competition, supply chain disruptions, safety concerns regarding the misuse of OTC medications, rivalry from prescription drugs, and shifting consumer preferences toward natural or alternative remedies or remedies.
In June 2020, Johnson & Johnson has introduced new over-the-counter (OTC) products to alleviate prevalent symptoms associated with COVID-19. (Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163789/)
A growing number of consumers are becoming more conscious of the importance of health and wellness, which is one of the key causes that is driving the expansion of the market for over-the-counter substances. As more people become aware of the importance of their health, there has been an increase in the demand for over-the-counter (OTC) drugs that are readily available without the need for a prescription. This tendency is especially obvious in metropolitan regions, where individuals have greater access to information and healthcare facilities than they have in rural ones.
Another substantial factor that contributes to the expansion of the OTC market is the trend toward self-medication. Consumers are increasingly choosing to treat common maladies, including colds, migraines, and minor injuries, with over-the-counter medications rather than consulting with a physician. The convenience and cost-effectiveness of over-the-counter medications are the primary factors driving this change, which enables individuals to more independently manage their health. Additionally, the OTC market is significantly influenced by the expanding geriatric population. A person's likelihood of developing chronic conditions and trivial health issues that can be treated with over-the-counter medications increases as they age.
The OTC market can be influenced by economic factors, such as fluctuations in exchange rates for currencies and inflation. The cost of basic materials and production can be influenced by these factors, resulting in increased prices for consumers. Furthermore, economic downturns may result in a decrease in consumer expenditure on non-essential items, such as over-the-counter medications. Additionally, the availability of over-the-counter medications may be affected by supply chain disruptions, such as those resulting from natural disasters or geopolitical events. This can result in shortages and increased costs, which can have a detrimental impact on the market.
The General OTC Market, in particular, was significantly affected by the COVID-19 pandemic. Sales experienced a significant increase as a result of the surge in demand for over-the-counter medications to alleviate symptoms such as cold, cough, and flu, which were frequently linked to COVID-19. Finally, the demand for over-the-counter (OTC) medicines was further stimulated by lockdowns and movement restrictions, which encouraged consumers to accumulate these medications. In addition, the pandemic disrupted supply chains, resulting in delays and shortages of specific over-the-counter medications. In conclusion, the pandemic not only increased the demand for over-the-counter (OTC) medications, but it also emphasized the need to address regulatory challenges and vulnerabilities in the supply chain.
We have various report editions of General OTC Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
In the General OTC market's competitive landscape, numerous key competitors are driving innovation and growth. As organizations endeavor to fortify their market positions and broaden their product offerings, mergers and acquisitions are also becoming increasingly prevalent in the marketplace. Furthermore, there is an increasing emphasis on the exploration of emergent markets, particularly in the Asia-Pacific and Latin America regions, where the demand for over-the-counter medications is on the rise as a result of economic growth and heightened healthcare awareness.
In August 2021, Procter & Gamble expanded its OTC drug distribution channels, which included online pharmacies, to accommodate the increasing consumer preference for e-commerce. (Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804119/) In February 2023, Emami Limited introduced novel over-the-counter dermatology products to address prevalent skin conditions. (Source: https://www.emamiltd.in/wp-content/themes/emami/pdf/Annual-Reports/2022-2023/20230801083247small52.pdf) In July 2023, GlaxoSmithKline enhanced its supply chain networks to mitigate disruptions emanating from global events. (Source: https://www.gsk.com/en-gb/media/press-releases/gsk-launches-sustainable-procurement-programme-for-suppliers/)
Top Companies Market Share in General OTC Industry: (In no particular order of Rank)
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
According to Cognitive Market Research, North America currently dominates the General OTCs market, and the region is expected to have significant growth during the projected period. North American consumers are increasingly cognizant of the advantages of over-the-counter medications and are becoming more health-conscious. The demand for over-the-counter (OTC) products that are readily accessible without a prescription is being driven by this awareness.
Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR). The penetration of over-the-counter pharmaceuticals has increased significantly in countries such as China and India. This is a result of the expanding middle class and the increased availability of healthcare products.
The current report Scope analyzes General OTC Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only. To learn more about geographical trends request the free sample pages. Contact US!
According to Cognitive Market Research, the global General OTC market size was estimated at USD 50254.2 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 20101.68 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.2% from 2024 to 2031.
According to Cognitive Market Research, the global General OTC market size was estimated at USD 50254.2 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 15076.26 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.5% from 2024 to 2031.
According to Cognitive Market Research, the global General OTC market size was estimated at USD 50254.2 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 11558.47 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.0% from 2024 to 2031.
According to Cognitive Market Research, the global General OTC market size was estimated at USD 50254.2 Million, out of which the Latin America held the market share of around 5% of the global revenue with a market size of USD 2512.71 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.4% from 2024 to 2031.
According to Cognitive Market Research, the global General OTC market size was estimated at USD 50254.2 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 1005.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.7% from 2024 to 2031..
Global General OTC Market Report 2024 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing General OTC Industry growth. General OTC market has been segmented with the help of its Type, Application , and others. General OTC market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
According to Cognitive Market Research, Cough, Cold, and Flu Products category are likely to dominate the General OTC Market over the forecast period. This is primarily attributable to the high prevalence of respiratory infections and the widespread desire for immediate respite from symptoms such as coughing, colds, and flu. These products are a fixture in households and pharmacies global, as the demand for them remains consistently high, particularly during the cold and flu seasons.
The Vitamins, Mineral, and Supplements (VMS) is the fastest-growing segment in the General OTC Market. This rise is driven by the rising consumer consciousness of health and wellness, as well as the increasing prevalence of self-medication. People are increasingly taking an active role in their health, which has resulted in a greater demand for products that address their nutritional requirements, immune health, and overall well-being.
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of General OTC Industry. Request a Free Sample PDF!
According to Cognitive Market Research, the Retail Pharmacies segment holds the largest share of the market. Retail pharmacies are the primary site of purchase for consumers due to their widespread accessibility and extensive selection of over-the-counter medications. Their dominant market position is a result of their extensive distribution network and the convenience they provide to consumers.
In the General OTC Market, the Online Pharmacy sector has been expanding at a rapid pace. The development of online pharmacies has been considerably accelerated by the increasing consumer preference for online purchasing and the rise of e-commerce. They attract a greater number of consumers, particularly in urban areas, due to their competitive pricing, extensive product selection, and ease of home delivery.
The above Graph is for representation purposes only. This chart does not depict actual Market share. Please purchase the General OTC market report 2024 Edition by contacting our team.
Senior Research Associate at Cognitive Market Research
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over three years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies.
In her current role, Manjiri handles the market research related to Pharma and healthcare industry. Her passion lies in utilizing innovative approaches to distill complex information into strategic insights that empower organizations to make informed decisions.Manjiri remains an invaluable asset in the dynamic landscape of market research.
Conclusion
Disclaimer:
Type | Cough, Cold, and Flu Products, Analgesics, Dermatology Products, Gastrointestinal Products, Vitamins, Mineral, and Supplements (VMS), Others |
Application | Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, Other Distribution Channels |
List of Competitors | Dr. Reddy?s Laboratories, Bayer, Sanofi, Teva Pharmaceuticals, Pfizer, Johnson and Johnson, Glaxosmithkline PLC, Takeda, Bayer AG, Cipla, Novartis AG, Confidential Data, Access The Paid Version, Data Hidden |
This chapter will help you gain GLOBAL Market Analysis of General OTC. Further deep in this chapter, you will be able to review Global General OTC Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
Chapter 2 North America Market Analysis
Purchase Add-Ons to Customize the Report Edition and get further granular data level data about the North America market. Add-On Cost: Request before placing the order, Respective Pricing will be informed after sending the inquiry
Qualitative Analysis for the North America Market: North America General OTC Market Trends North America General OTC Technological Road Map North America General OTC Market Drivers North America General OTC Market Restraints North America General OTC Market Opportunity Market Attractiveness Analysis COVID – 19 Impact Analysis PESTEL Analysis Porter’s Five Forces Analysis Product Life Cycle Industrial Chain Analysis
You can purchase only the Executive Summary North America Market (2019 vs 2024 vs 2031)
Chapter 3 Europe Market Analysis
You can purchase only the Executive Summary Europe Market (2019 vs 2024 vs 2031)
Chapter 4 Asia-Pacific Market Analysis
You can purchase only the Executive Summary Asia Pacific Market (2019 vs 2024 vs 2031)
Chapter 5 South America Market Analysis
You can purchase only the Executive Summary South America Market (2019 vs 2024 vs 2031)
Chapter 6 Middle East and Africa Market Analysis
You can purchase only the Executive Summary Middle East and Africa Market (2019 vs 2024 vs 2031)
Only Available with Corporate User License
Chapter 7 Top 10 Countries Analysis
Competitor's Market Share and Revenue (Subject to Data Availability for Private Players)
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
Segmentation Type Analysis 2019 -2031, will provide market size split by Type. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Type Analysis 2019 -2031
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Application Analysis 2019 -2031
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global General OTC market
Chapter 12 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Why Cough have a significant impact on General OTC market? |
What are the key factors affecting the Cough and Cold of General OTC Market? |
What is the CAGR/Growth Rate of Hospital Pharmacies during the forecast period? |
By type, which segment accounted for largest share of the global General OTC Market? |
Which region is expected to dominate the global General OTC Market within the forecast period? |
Segmentation Level Customization |
|
Global level Data Customization |
|
Region level Data Customization |
|
Country level Data Customization |
|
Company Level |
|
Additional Data Analysis |
|
Additional Qualitative Data |
|
Additional Quantitative Data |
|
Service Level Customization |
|
Report Format Alteration |
|
Published Report Editions
are Just a Tip of an Iceberg
Access the Complete Database of
General OTC Market
Request Sample